Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Inarigivir soproxil (SB9200) 是一种先天免疫激动剂。 它还显示出针对耐药丙型肝炎病毒 (HCV) 变体的有效抗病毒活性。在基因型 1 HCV 复制子系统细胞中, HCV 1a/1b 的 EC50 为 2.2 和 1.0 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,280 | 现货 | ||
5 mg | ¥ 2,890 | 现货 | ||
10 mg | ¥ 4,370 | 现货 | ||
25 mg | ¥ 8,230 | 现货 | ||
50 mg | ¥ 10,900 | 现货 | ||
100 mg | ¥ 14,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 4,490 | 现货 |
产品描述 | Inarigivir soproxil (SB9200) is an agonist of innate immunity. It also displays effective antiviral activity against resistant hepatitis C virus (HCV) variants (EC50s of 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype 1 HCV replicon systems). |
靶点活性 | HCV 1a/1b:(EC50)2.2/1.0 μM |
体外活性 | Inarigivir soproxil is shown to inhibit HCV replication and the range of inhibition is comparable between genotypes 1a and 1b. Inarigivir soproxil is an oral modulator of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways. Inarigivir soproxil demonstrates pan-genotypic antiviral activity against HCV. Inarigivir soproxil is active against DAA-resistant HCV variants. SB 9200 has broad-spectrum antiviral activity against RNA viruses including hepatitis C virus (HCV), norovirus, respiratory syncytial virus and influenza and has demonstrated activity against hepatitis B virus (HBV)[1]. |
别名 | SB9200 |
分子量 | 703.62 |
分子式 | C25H34N7O13PS |
CAS No. | 942123-43-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 102 mg/mL (144.96 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.4212 mL | 7.1061 mL | 14.2122 mL | 35.5305 mL |
5 mM | 0.2842 mL | 1.4212 mL | 2.8424 mL | 7.1061 mL | |
10 mM | 0.1421 mL | 0.7106 mL | 1.4212 mL | 3.5531 mL | |
20 mM | 0.0711 mL | 0.3553 mL | 0.7106 mL | 1.7765 mL | |
50 mM | 0.0284 mL | 0.1421 mL | 0.2842 mL | 0.7106 mL | |
100 mM | 0.0142 mL | 0.0711 mL | 0.1421 mL | 0.3553 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Inarigivir soproxil 942123-43-5 Microbiology/Virology Proteases/Proteasome HCV Protease inhibit Inhibitor HCV replicon GS-9992 GS9992 antiviral activity against HCV Hepatitis C virus innate immunity SB9200 GS 9992 SB-9200 HBV Hepatitis B virus SB 9200 inhibitor